Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Thyroid tumors].

K W Schmid1, S-Y Sheu, R Görges

  • 1Institut für Pathologie, Universitätsklinikum Essen, Germany. kw.schmid.pathologie@uni-essen.de

Der Pathologe
|September 10, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fibroblast activation protein-α expression in fibroblasts is common in the tumor microenvironment of colorectal cancer and may serve as a therapeutic target.

Pathology oncology research : POR·2023
Same author

A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma.

Journal of cancer research and clinical oncology·2022
Same author

[Hemithyroidectomy or total thyroidectomy for low-risk papillary thyroid cancer? : Surgical criteria for primary and secondary choice of treatment in an interdisciplinary treatment concept].

Chirurgie (Heidelberg, Germany)·2022
Same author

Multimodal survival prediction in advanced pancreatic cancer using machine learning.

ESMO open·2022
Same author

[Nodular tumour of the Vas deferens with epithelial structures].

Der Pathologe·2021
Same author

Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK).

Langenbeck's archives of surgery·2021
Same journal

[Connective (tissue) pathology: What brings us together!]

Der Pathologe·2022
Same journal

[Giant cell-containing tumors of bone and differential diagnoses].

Der Pathologe·2022
Same journal

[Automation and application of robotics in the pathology laboratory].

Der Pathologe·2022
Same journal

[Practical diagnostic aspects of uterine leiomyosarcoma in the context of the 2020 WHO classification].

Der Pathologe·2022
Same journal

[Artificial intelligence: a solution for the lack of pathologists?]

Der Pathologe·2022
Same journal

[Predictive immunocytochemistry in non-small cell lung carcinoma].

Der Pathologe·2022
See all related articles

Thyroid adenomas are common, but thyroid carcinomas are rare malignancies. This paper details standardized pathology methods for diagnosing thyroid tumors, including variants, using gross examination, histology, and advanced techniques.

Area of Science:

  • Endocrinology
  • Oncology
  • Pathology

Context:

  • Thyroid tumors encompass a spectrum from benign adenomas to malignant carcinomas.
  • Thyroid carcinomas represent a small fraction (1%) of all human malignancies.
  • Accurate differential diagnosis between thyroid adenoma and carcinoma is crucial in routine pathology.

Purpose:

  • To outline standardized gross and histological examination protocols for thyroid tumors.
  • To evaluate the utility of immunohistochemistry in differentiating thyroid lesions.
  • To assess the impact of intraoperative frozen sections on thyroid pathology diagnosis.

Summary:

  • This paper provides a comprehensive guide to the pathological assessment of thyroid tumors.
  • It details systematic approaches for gross and microscopic evaluation.

Related Experiment Videos

  • The role of immunohistochemistry and frozen section analysis in improving diagnostic accuracy is discussed.

    • Impact:

    • Enhances diagnostic accuracy in distinguishing benign thyroid adenomas from malignant thyroid carcinomas.
    • Provides essential information for clinicians managing patients with thyroid nodules.
    • Contributes to the standardized practice of thyroid pathology, improving patient outcomes.